Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Salgado

Showing results (171-180 of 277) with videos related to

Pageof 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2018
Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast CancerHope S Rugo, Jean-Pierre Delord, Seock-Ah Im, et al.
NPJ Breast Cancer|March 2, 2019
<i>ESR1</i> mutations in metastatic lobular breast cancer patientsChristine Desmedt, Julien Pingitore, Françoise Rothé, et al.
Cancers|October 27, 2022
Comparative Evaluation of Tumor-Infiltrating Lymphocytes in Companion Animals: Immuno-Oncology as a Relevant Translational Model for Cancer TherapyChristopher J Pinard, , Andrew Lagree, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2023
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)Holly Tovey, Orsolya Sipos, Joel S Parker, et al.
JAMA Oncology|December 4, 2015
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer RecurrenceMichail Ignatiadis, Hatem A Azim, Christine Desmedt, et al.
International Journal of Radiation Oncology, Biology, Physics|September 27, 2025
Analysis of the Radiosensitivity Index in Paired Preneoadjuvant and Postneoadjuvant Therapy Triple-Negative Breast CancerShane R Stecklein, Roberto Salgado, Julia R White, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2022
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast CancersPatrycja Gazinska, Charlotte Milton, Jacopo Iacovacci, et al.
Breast Cancer Research and Treatment|April 3, 2023
Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristicsShahin Sayed, Hela Koka, Mustapha Abubakar, et al.
Nature Communications|September 21, 2017
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancerSathana Dushyanthen, Zhi Ling Teo, Franco Caramia, et al.
Journal for Immunotherapy of Cancer|December 6, 2023
First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trialAlex De Caluwe, Emanuela Romano, Philip Poortmans, et al.
Pageof 28

Showing results (171-180 of 277) with videos related to

Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2018
Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast CancerHope S Rugo, Jean-Pierre Delord, Seock-Ah Im, et al.
NPJ Breast Cancer|March 2, 2019
<i>ESR1</i> mutations in metastatic lobular breast cancer patientsChristine Desmedt, Julien Pingitore, Françoise Rothé, et al.
Cancers|October 27, 2022
Comparative Evaluation of Tumor-Infiltrating Lymphocytes in Companion Animals: Immuno-Oncology as a Relevant Translational Model for Cancer TherapyChristopher J Pinard, , Andrew Lagree, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2023
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)Holly Tovey, Orsolya Sipos, Joel S Parker, et al.
JAMA Oncology|December 4, 2015
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer RecurrenceMichail Ignatiadis, Hatem A Azim, Christine Desmedt, et al.
International Journal of Radiation Oncology, Biology, Physics|September 27, 2025
Analysis of the Radiosensitivity Index in Paired Preneoadjuvant and Postneoadjuvant Therapy Triple-Negative Breast CancerShane R Stecklein, Roberto Salgado, Julia R White, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2022
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast CancersPatrycja Gazinska, Charlotte Milton, Jacopo Iacovacci, et al.
Breast Cancer Research and Treatment|April 3, 2023
Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristicsShahin Sayed, Hela Koka, Mustapha Abubakar, et al.
Nature Communications|September 21, 2017
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancerSathana Dushyanthen, Zhi Ling Teo, Franco Caramia, et al.
Journal for Immunotherapy of Cancer|December 6, 2023
First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trialAlex De Caluwe, Emanuela Romano, Philip Poortmans, et al.
Pageof 28